
Delilah Alvarado
Associate EditorDelilah is an associate editor for BioPharma Dive. Before Industry Dive she covered business tech and startup news and has reported on social issues, politics and culture. She has a B.S. from Texas State University and is obsessed with dogs and horror films.
141 articles by Delilah Alvarado
-
FDA staff appear supportive of RSV drug from AstraZeneca, Sanofi
June 6, 2023 -
Pfizer says antibiotic is effective against tough-to-treat infections
June 2, 2023 -
AstraZeneca abandons experimental bowel disease drug
June 1, 2023 -
Pfizer’s RSV vaccine wins FDA approval in older adults
May 31, 2023 -
Biohaven sends latest drug to FDA, despite past trial setback
May 31, 2023 -
Amylyx’s ALS drug could face rejection in Europe
May 30, 2023 -
BenevolentAI CFO resigns as company lays off staff, restructures
May 25, 2023 -
FDA approves new antibiotic for hospital-acquired pneumonia
May 24, 2023 -
FDA approves Krystal gene therapy for rare wound disorder
May 22, 2023 -
Novavax cuts workforce by 25% as COVID vaccine sales fall
May 9, 2023 -
Former Rubius, Laronde CEO Cagnoni to join Incyte
May 8, 2023 -
Convergent raises $90M to develop its radiopharmaceutical for prostate cancer
May 5, 2023 -
Valneva, Pfizer push back timeline for Lyme disease vaccine
May 4, 2023 -
FDA approves first RSV vaccine, clearing GSK’s Arexvy for older adults
May 3, 2023 -
J&J, building on CAR-T success, strikes another cell therapy deal
May 2, 2023 -
FDA clears Pfizer’s pneumococcal vaccine for infants and children
April 28, 2023 -
Novartis plant cleared to produce in-demand cancer drug
April 24, 2023 -
Supreme Court maintains access to abortion pill, blocking restrictions on its use
April 21, 2023 -
Supreme Court delays decision in battle over abortion pill
April 19, 2023 -
FDA favors single dose of updated COVID shots in shift to simplify vaccination
April 18, 2023 -
Vaxcyte strengthens case for experimental pneumococcal vaccine
April 17, 2023 -
Appeals court rules abortion drug can stay on market — but limits access
April 13, 2023 -
Century Therapeutics changes leadership as CEO steps down
April 12, 2023 -
Biotech fears ‘dangerous’ precedent as judge challenges FDA authority
April 10, 2023 -
Federal judge invalidates FDA approval of abortion pill
April 8, 2023